Neuroone Medical Technologies (NMTC) Receivables - Net (2020 - 2026)

Neuroone Medical Technologies' Receivables - Net history runs 7 years deep, the most recent figure standing at $1.9 million for Q1 2026.

• Quarterly Receivables - Net rose 495.2% year-over-year to $1.9 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $1.9 million (up 495.2% YoY) and the FY2025 annual result came in at $1.3 million, up 616.05% from the prior year.
• Receivables - Net was $1.9 million for Q1 2026 at Neuroone Medical Technologies, down from $2.7 million in the prior quarter.
• Across five years, Receivables - Net topped out at $2.7 million in Q4 2025 and bottomed at $33237.0 in Q3 2022.
• A 5-year average of $813620.4 and a median of $410551.0 in 2024 frame the typical range for Receivables - Net.
• Peak annual rise in Receivables - Net reached 616.05% in 2025, while the deepest fall reached 42.63% in 2025.
• Neuroone Medical Technologies' Receivables - Net stood at $95319.0 in 2022, then jumped by 470.08% to $543399.0 in 2023, then surged by 335.94% to $2.4 million in 2024, then grew by 12.37% to $2.7 million in 2025, then declined by 28.72% to $1.9 million in 2026.
• Business Quant data shows NMTC's Receivables - Net at $1.9 million in Q1 2026, $2.7 million in Q4 2025, and $1.3 million in Q3 2025.